Literature DB >> 22839749

Acute HIV-1 infection in the Southeastern United States: a cohort study.

Mehri S McKellar1, Anna B Cope, Cynthia L Gay, Kara S McGee, Joann D Kuruc, Melissa G Kerkau, Christopher B Hurt, Susan A Fiscus, Guido Ferrari, David M Margolis, Joseph J Eron, Charles B Hicks.   

Abstract

In 1998 a collaboration between Duke University and the University of North Carolina, Chapel Hill (UNC) was founded to enhance identification of persons with acute HIV-1 infection (AHI). The Duke-UNC AHI Research Consortium Cohort consists of patients ≥18 years old with a positive nucleic acid amplification test (NAAT) and either a negative enzyme immunoassay (EIA) test or a positive EIA with a negative/indeterminate Western blot. Patients were referred to the cohort from acute care settings and state-funded HIV testing sites that use NAAT testing on pooled HIV-1 antibody-negative samples. Between 1998 and 2010, 155 patients with AHI were enrolled: 81 (52%) African-Americans, 63 (41%) white, non-Hispanics, 137 (88%) males, 108 (70%) men who have sex with men (MSM), and 18 (12%) females. The median age was 27 years (IQR 22-38). Most (n=138/155) reported symptoms with a median duration of 17.5 days. The median nadir CD4 count was 408 cells/mm(3) (IQR 289-563); the median observed peak HIV-1 level was 726,859 copies/ml (IQR 167,585-3,565,728). The emergency department was the most frequent site of initial presentation (n=55/152; 3 missing data). AHI diagnosis was made at time of first contact in 62/137 (45%; 18 missing data) patients. This prospectively enrolled cohort is the largest group of patients with AHI reported from the Southeastern United States. The demographics reflect the epidemic of this geographic area with a high proportion of African-Americans, including young black MSM. Highlighting the challenges of diagnosing AHI, less than half of the patients were diagnosed at the first healthcare visit. Women made up a small proportion despite increasing numbers in our clinics.

Entities:  

Mesh:

Year:  2012        PMID: 22839749      PMCID: PMC3537297          DOI: 10.1089/aid.2012.0064

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  28 in total

1.  Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. The Swiss HIV Cohort Study.

Authors:  P L Vernazza; L Troiani; M J Flepp; R W Cone; J Schock; F Roth; K Boggian; M S Cohen; S A Fiscus; J J Eron
Journal:  AIDS       Date:  2000-01-28       Impact factor: 4.177

2.  Efficacy of NNRTI-based antiretroviral therapy initiated during acute HIV infection.

Authors:  Cynthia L Gay; Ashley J Mayo; Chelu K Mfalila; Haitao Chu; Anna C Barry; JoAnn D Kuruc; Kara S McGee; Melissa Kerkau; Joe Sebastian; Susan A Fiscus; David M Margolis; Charles B Hicks; Guido Ferrari; Joseph J Eron
Journal:  AIDS       Date:  2011-04-24       Impact factor: 4.177

3.  Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group.

Authors:  T C Quinn; M J Wawer; N Sewankambo; D Serwadda; C Li; F Wabwire-Mangen; M O Meehan; T Lutalo; R H Gray
Journal:  N Engl J Med       Date:  2000-03-30       Impact factor: 91.245

4.  Prevention of HIV-1 infection with early antiretroviral therapy.

Authors:  Myron S Cohen; Ying Q Chen; Marybeth McCauley; Theresa Gamble; Mina C Hosseinipour; Nagalingeswaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Beatriz Grinsztejn; Jose H S Pilotto; Sheela V Godbole; Sanjay Mehendale; Suwat Chariyalertsak; Breno R Santos; Kenneth H Mayer; Irving F Hoffman; Susan H Eshleman; Estelle Piwowar-Manning; Lei Wang; Joseph Makhema; Lisa A Mills; Guy de Bruyn; Ian Sanne; Joseph Eron; Joel Gallant; Diane Havlir; Susan Swindells; Heather Ribaudo; Vanessa Elharrar; David Burns; Taha E Taha; Karin Nielsen-Saines; David Celentano; Max Essex; Thomas R Fleming
Journal:  N Engl J Med       Date:  2011-07-18       Impact factor: 91.245

5.  The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study.

Authors:  Kimberly A Powers; Azra C Ghani; William C Miller; Irving F Hoffman; Audrey E Pettifor; Gift Kamanga; Francis Ea Martinson; Myron S Cohen
Journal:  Lancet       Date:  2011-07-16       Impact factor: 79.321

6.  Diagnosis of primary HIV-1 infection. Los Angeles County Primary HIV Infection Recruitment Network.

Authors:  E S Daar; S Little; J Pitt; J Santangelo; P Ho; N Harawa; P Kerndt; J V Glorgi; J Bai; P Gaut; D D Richman; S Mandel; S Nichols
Journal:  Ann Intern Med       Date:  2001-01-02       Impact factor: 25.391

7.  Diagnosis of primary HIV-1 infection and duration of follow-up after HIV exposure. Karolinska Institute Primary HIV Infection Study Group.

Authors:  S Lindbäck; R Thorstensson; A C Karlsson; M von Sydow; L Flamholc; A Blaxhult; A Sönnerborg; G Biberfeld; H Gaines
Journal:  AIDS       Date:  2000-10-20       Impact factor: 4.177

8.  Real-time, universal screening for acute HIV infection in a routine HIV counseling and testing population.

Authors:  Christopher D Pilcher; J Todd McPherson; Peter A Leone; Marlene Smurzynski; Judy Owen-O'Dowd; Amy L Peace-Brewer; Juanita Harris; Charles B Hicks; Joseph J Eron; Susan A Fiscus
Journal:  JAMA       Date:  2002-07-10       Impact factor: 56.272

9.  Cross-sectional detection of acute HIV infection: timing of transmission, inflammation and antiretroviral therapy.

Authors:  Cynthia Gay; Oliver Dibben; Jeffrey A Anderson; Andrea Stacey; Ashley J Mayo; Philip J Norris; JoAnn D Kuruc; Jesus F Salazar-Gonzalez; Hui Li; Brandon F Keele; Charles Hicks; David Margolis; Guido Ferrari; Barton Haynes; Ronald Swanstrom; George M Shaw; Beatrice H Hahn; Joseph J Eron; Persephone Borrow; Myron S Cohen
Journal:  PLoS One       Date:  2011-05-10       Impact factor: 3.240

10.  Estimated HIV incidence in the United States, 2006-2009.

Authors:  Joseph Prejean; Ruiguang Song; Angela Hernandez; Rebecca Ziebell; Timothy Green; Frances Walker; Lillian S Lin; Qian An; Jonathan Mermin; Amy Lansky; H Irene Hall
Journal:  PLoS One       Date:  2011-08-03       Impact factor: 3.240

View more
  25 in total

1.  Broadly-specific cytotoxic T cells targeting multiple HIV antigens are expanded from HIV+ patients: implications for immunotherapy.

Authors:  Sharon Lam; Julia Sung; Conrad Cruz; Paul Castillo-Caro; Minhtran Ngo; Carolina Garrido; Joann Kuruc; Nancie Archin; Cliona Rooney; David Margolis; Catherine Bollard
Journal:  Mol Ther       Date:  2014-11-04       Impact factor: 11.454

Review 2.  Sex, age, race and intervention type in clinical studies of HIV cure: a systematic review.

Authors:  Rowena E Johnston; Mary M Heitzeg
Journal:  AIDS Res Hum Retroviruses       Date:  2015-01       Impact factor: 2.205

3.  Leveraging Phylogenetics to Understand HIV Transmission and Partner Notification Networks.

Authors:  Dana K Pasquale; Irene A Doherty; Lynne A Sampson; Stephane Hué; Peter A Leone; Joseph Sebastian; Sue L Ledford; Joseph J Eron; William C Miller; Ann M Dennis
Journal:  J Acquir Immune Defic Syndr       Date:  2018-08-01       Impact factor: 3.731

4.  A Simple Symptom Score for Acute Human Immunodeficiency Virus Infection in a San Diego Community-Based Screening Program.

Authors:  Timothy C Lin; Sara Gianella; Tara Tenenbaum; Susan J Little; Martin Hoenigl
Journal:  Clin Infect Dis       Date:  2018-06-18       Impact factor: 9.079

5.  Incident sexually transmitted infection as a biomarker for high-risk sexual behavior after diagnosis of acute HIV.

Authors:  Anna B Cope; Amanda M Crooks; Tammy Chin; JoAnn D Kuruc; Kara S McGee; Joseph J Eron; Charles B Hicks; Lisa B Hightow-Weidman; Cynthia L Gay
Journal:  Sex Transm Dis       Date:  2014-07       Impact factor: 2.830

Review 6.  The HIV treatment cascade in acutely infected people: informing global guidelines.

Authors:  Sarah E Rutstein; Christopher J Sellers; Jintanat Ananworanich; Myron S Cohen
Journal:  Curr Opin HIV AIDS       Date:  2015-11       Impact factor: 4.283

7.  Fixed-dose combination emtricitabine/tenofovir/efavirenz initiated during acute HIV infection; 96-week efficacy and durability.

Authors:  Cynthia L Gay; Sarah J Willis; Anna B Cope; JoAnn D Kuruc; Kara S McGee; Joe Sebastian; Amanda M Crooks; Mehri S McKellar; David M Margolis; Susan A Fiscus; Charles B Hicks; Guido Ferrari; Joseph J Eron
Journal:  AIDS       Date:  2016-11-28       Impact factor: 4.177

8.  Phylogenetic Investigation of a Statewide HIV-1 Epidemic Reveals Ongoing and Active Transmission Networks Among Men Who Have Sex With Men.

Authors:  Philip A Chan; Joseph W Hogan; Austin Huang; Allison DeLong; Marco Salemi; Kenneth H Mayer; Rami Kantor
Journal:  J Acquir Immune Defic Syndr       Date:  2015-12-01       Impact factor: 3.731

9.  Antiretroviral therapy initiated during acute HIV infection fails to prevent persistent T-cell activation.

Authors:  Michael J Vinikoor; Anna Cope; Cynthia L Gay; Guido Ferrari; Kara S McGee; Joann D Kuruc; Jeffrey L Lennox; David M Margolis; Charles B Hicks; Joseph J Eron
Journal:  J Acquir Immune Defic Syndr       Date:  2013-04-15       Impact factor: 3.731

10.  Prevalence of undiagnosed acute and chronic HIV in a lower-prevalence urban emergency department.

Authors:  Phillip C Moschella; Kimberly W Hart; Andrew H Ruffner; Christopher J Lindsell; D Beth Wayne; Matthew I Sperling; Alexander T Trott; Carl J Fichtenbaum; Michael S Lyons
Journal:  Am J Public Health       Date:  2014-07-17       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.